19 results
6-K
EX-99.1
LEGN
Legend Biotech Corporation
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
and safety procedures outlined in Section 3.9 (Health and Safety Procedures), (b) [***], and (c) will not be used or delivered to or for the benefit of any … with Collaboration Partners at all times.
Health and Safety Procedures. Provider will be responsible for implementing and maintaining health and safety
6-K
EX-1.1
LEGN
Legend Biotech Corporation
27 Jul 22
Announces Pricing of Public Offering
4:35pm
, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes
424B5
kjwa 8e7ilxi9w2pa
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
xx904xjz
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.4
2up nmx42qqi04fd
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
EX-1.1
uqieu
17 Dec 21
Announces Pricing of Public Offering
4:19pm
20-F
03zv3uj01e2
2 Apr 21
Annual report (foreign)
8:10am
20-F
EX-4.8
purl drl8w3cex0
2 Apr 21
Annual report (foreign)
8:10am
424B4
m5pcdqs3p3q p6pn
8 Jun 20
Prospectus supplement with pricing info
9:07am
F-1/A
tpu viwg0sv
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1/A
EX-99.1
pe3kr40g9s9utgl
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1/A
EX-1.1
xur95jhseks he
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1
gzfekgcngkc6
13 May 20
Registration statement (foreign)
4:41pm
DRS/A
fik c1tg8ptfr41ecbd
8 May 20
Draft registration statement (amended)
12:00am
DRS/A
wp3eyjg118j d1
20 Apr 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next